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ABSTRACT Outer membrane vesicles (OMV) are proposed to mediate multiple functions during pathogenesis and symbiosis.
However, the mechanisms responsible for OMV formation remain poorly understood. It has been shown in eukaryotic mem-
branes that lipids with an inverted-cone shape favor the formation of positive membrane curvatures. Based on these studies, we
formulated the hypothesis that lipid A deacylation might impose shape modifications that result in the curvature of the outer
membrane (OM) and subsequent OMV formation.We tested the effect of lipid A remodeling on OMV biogenesis employing
Salmonella enterica serovar Typhimurium as a model organism. Expression of the lipid A deacylase PagL resulted in increased
vesiculation, without inducing an envelope stress response. Mass spectrometry analysis revealed profound differences in the
patterns of lipid A in OM and OMV, with accumulation of deacylated lipid A forms exclusively in OMV. OMV biogenesis by in-
tracellular bacteria uponmacrophage infection was drastically reduced in a pagLmutant strain. We propose a novel mechanism
for OMV biogenesis requiring lipid A deacylation in the context of a multifactorial process that involves the orchestrated remod-
eling of the outer membrane.
IMPORTANCE The role of lipid remodeling in vesiculation is well documented in eukaryotes. Similarly, bacteria produce
membrane-derived vesicles; however, the molecular mechanisms underlying their production are yet to be determined. In this
work, we investigated the role of outer membrane remodeling in OMV biogenesis in S. Typhimurium.We showed that the ex-
pression of the lipid A deacylase PagL results in overvesiculation with deacylated lipid A accumulation exclusively in OMV. An
S. TyphimuriumpagL strain showed a significant reduction in intracellular OMV secretion relative to the wild-type strain. Our
results suggest a novel mechanism for OMV biogenesis that involves outer membrane remodeling through lipid Amodification.
Understanding howOMV are produced by bacteria is important to advance our understanding of the host-pathogen interac-
tions.
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Outer membrane vesicles (OMV) are liposomal structuresprotruding from the outer membrane (OM) of Gram-
negative bacteria. They have been proposed to mediate numerous
functions in environmental bacteria, pathogens, and symbionts
(1, 2). These roles involve quorum sensing, horizontal gene trans-
fer, interbacterial killing, toxin delivery, hydrolysis of polysaccha-
rides, and secretion of misfolded proteins to relieve cell envelope
stress (1–7). Several models for OMV biogenesis have been sug-
gested (1, 2, 8, 9). However, the molecular mechanisms leading to
OMV formation are not well understood. OMV share the basic
components with the parent OM, including OM proteins, phos-
pholipids, and lipopolysaccharides (LPS). Despite the similarity in
general composition between the OM and OMV, OMV appear to
carry specific protein cargo in some bacteria (1, 10–15). More-
over, lipid analysis of the two compartments in several bacteria
suggested the enrichment of specific lipid species in OMV com-
pared to the OM (9, 13, 16, 17). These observations imply that OM
remodeling occurs before the blebbing of the OMV. We have
shown that OMV produced by the dental pathogen Porphyromo-
nas gingivalis are enriched in deacylated lipid A forms compared to
the lipid A purified from the cells (14). Lipid A is an acylated
disaccharide and constitutes the hydrophobic anchor of LPS in the
outer leaflet of the OM. Because lipid A deacylation is best studied
in Salmonella (18–20), we chose this organism to test our model
that lipid A deacylation is involved in OMV formation.
Salmonella enterica serovar Typhimurium (referred to as S. Ty-
phimurium) is a leading cause of gastroenteritis, with approxi-
mately 3 million deaths reported annually worldwide (21). S. Ty-
phimurium possesses a plethora of virulence factors that are
required for disease development. Many of these virulence factors
are encoded within horizontally acquired genomic islands called
Salmonella pathogenicity islands (SPI) (22). SPI-1 and SPI-2 are
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the main virulence determinants. Each of them encodes a different
type III secretion system (T3SS), which is a type of nanomachinery
capable of injecting bacterial effectors across the eukaryotic
plasma membrane into the host cell cytosol (23–27). In addition
to T3SS, it has been proposed that intracellular S. Typhimurium
can secrete its proteins via OMV (28). To minimize fitness trade-
offs in vivo, S. Typhimurium relies on two-component regulatory
systems to spatially and temporally regulate the expression of
genes within different SPIs (29). Following phagocytosis by mac-
rophages, S. Typhimurium resides in a specialized compartment,
termed the Salmonella-containing vacuole (SCV). The intravacu-
olar milieu activates the two-component system, PhoPQ (30).
Once activated, PhoPQ mediates lipid A modifications and OM
remodeling (31–33).
The secretion of LPS-positive vesicles by intracellular S. Typhi-
murium has been reported before (28, 34). A previous study dem-
onstrated the release of LPS by S. Typhimurium into the infected
epithelial cells. The secreted LPS was detected in multiple cellular
compartments, including the SCV and the host cell cytosol (34).
Recently, Guidi et al showed that S. Typhimurium can secrete
OMV packed with cytolethal distending toxin (CDT) inside in-
fected epithelial cells. The secreted vesicles tested positive for
S. Typhimurium LPS (28). Together, these results suggested that
S. Typhimurium produces OMV during its intracellular life.
Employing biophysical methods, it has been established that
fully acylated and deacylated lipid A adopt different spatial con-
figurations due to the variation in the cross sections of their hy-
drophobic moieties. Hexa-acylated lipid A is conical in shape,
while the deacylated forms tend to acquire cylindrical to inverted-
cone-shaped structures (35). The influence of lipid geometric
properties on membrane curvature is well studied in eukaryotes
(36). Lipids with inverted-cone-shaped structures, like lysophos-
phatidylcholine, favor the formation of positive membrane cur-
vatures (37). Based on these studies, we formulated the hypothesis
that lipid A deacylation might impose shape modifications that
result in the curvature of the OM and subsequent OMV forma-
tion. The S. Typhimurium enzyme PagL removes the -
hydroxymyristoyl chain in the 3 position of lipid A and is tightly
regulated by the PhoPQ two-component system (19). This mod-
ification makes lipid A, and hence S. Typhimurium, less detectable
by Toll-like receptor 4 (TLR-4) of the host immune cells (18).
Activation of PhoP-PhoQ also activates a second two-component
regulatory system, PmrA-PmrB, which promotes the attachment
of aminoarabinose and phosphoethanolamine to the phosphate
groups on lipid A. PagL-modified lipid A is not detected in
PhoPQ-activating conditions in vitro, but can occur in PmrA or
PmrB mutants, both of which lack the aminoarabinose modifica-
tion of lipid A. Because of the inhibitory effect of the aminoarabi-
nose lipid A modifications on PagL, the enzyme is considered to be
“latent” (38, 39).
In this work, we tested the hypothesis that accumulation of
deacylated lipid A molecules in the OM produced by PagL can
induce OMV formation (Fig. 1). We tested our model in vitro
using S. Typhimurium expressing active and inactive variants of
PagL. Moreover, we investigated the role of PagL in intracellular
OMV production.
RESULTS
OM and OMV share the same lipid A profile in the absence of
PagL expression. We initially compared the profiles of the lipid A
extracted from bacterial cells harvested from S. Typhimurium
grown in vitro under standard lab conditions with the profile of
the lipid A molecules obtained from OMV by mass spectrometry
(MS). This analysis revealed identical profiles in both the cellular
and OMV fractions. As shown in Fig. S1 in the supplemental ma-
terial, the bis-phosphorylated hexa-acylated lipid A was the pre-
dominant peak (m/z 1,796) in both spectra. In agreement with
previous reports, we did not detect any PagL-mediated deacylated
forms of lipid A in S. Typhimurium cells and OMV, which was
expected as PagL is not induced under the conditions employed
(38).
Construction of catalytically inactive variant of PagL. To
study the effect of PagL on vesiculation in vitro, we adopted a
biochemical approach. Instead of growing the bacteria under
PhoPQ-activating conditions, we expressed PagL recombinantly
in S. Typhimurium. This approach enabled us to study the effect
of PagL on OMV formation in the absence of other PhoPQ-
mediated lipid A modifications (40, 41).
To investigate whether lipid A deacylation can lead to OMV
formation, we cloned and expressed a His-tagged version of PagL.
FIG 1 Hypothetical model for PagL-mediated vesiculation in S. Typhimurium. During its intracellular life, S. Typhimurium will activate PagL in response to
host cues. PagL will deacylate lipid A, leading to a change in its topology. As a consequence, with the decrease in hydrophobic cross-section area, lipid A will adopt
an inverted-cone shape, leading to membrane curvature and OMV formation.
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To distinguish between possible effects caused by PagL expression
and not by its activity, we created a catalytically inactive variant of
PagL. Geurtsen et al. identified the conserved residues among
PagL homologues in different bacteria (42). Another study re-
vealed the catalytic mechanism for PagL and demonstrated that
histidine (position 163) and serine (position 165) residues are
essential for activity (43). Therefore, we performed site-directed
mutagenesis to change the latter residues to alanine, which should
abolish the deacylation activity. To confirm that PagLH163A S165A
was enzymatically inactive, we employed a modified in vitro assay
for lipid A deacylation. We expressed PagL and PagLH163A S165A in
Escherichia coli DH5ɑ, which lacks a homologue for pagL in the
genome (19, 42). Membrane preparations of different E. coli
strains expressing PagL, PagLH163A S165A, and the empty vector
were incubated with purified S. Typhimurium LPS overnight.
Following incubation, lipid A was extracted from the different
reactions and analyzed by MS. Only the expression of wild-type
PagL resulted in the detection of a peak corresponding to the
3-O-deacylated bis-phosphorylated lipid A (m/z 1,570). Con-
versely, the mutated variant of PagLH163A S165A (now referred to
as PagLinactive) lost its ability to deacylate lipid A, as indicated
by the absence of the m/z 1,570 peak (see Fig. S2 in the supple-
mental material).
Overexpression of active PagL increases OMV production.
To examine if lipid A deacylation is related to vesiculation, we
measured OMV production by S. Typhimurium transformants
expressing PagL and PagLinactive for 4 h from a low-copy-number
vector. Using immunoblotting, we verified that both PagL and
PagLinactive were expressed at equivalent levels (see Fig. S3 in the
supplemental material). Moreover, OMV were harvested from
cell-free supernatants of cultures normalized to the optical density
at 600 nm (OD600). Other studies relied on measuring the protein
concentration of OMV preparations as a representative of vesicu-
lation levels (6, 44–46). However, this approach does not take into
account that proteins, such as flagellins, associate in a nonspecific
manner with OMV, which can mask the results. Alternatively, we
employed a specific colorimetric assay to quantify the 3-deoxy-D-
manno-octulosonic acid (KDO) content in the OMV (47). KDO
is bound to lipid A at position 6= in many bacterial species (48). In
S. Typhimurium, two molecules of KDO covalently modify each
molecule of lipid A (49). Since lipid A is a principal component of
OMV, KDO levels are representative of the amounts of OMV
produced. As shown in Fig. 2, PagL expression resulted in about a
4-fold increase in OMV production compared to that of the vector
control. The expression of PagLinactive did not significantly in-
crease OMV production, compared to the vector control (Fig. 2).
To visualize vesiculation in vitro, we employed transmission elec-
tron microscopy (TEM). Strains carrying PagL and its inactive
variant were grown overnight on solid media. Bacteria were di-
rectly resuspended in phosphate-buffered saline (PBS) and fixated
for TEM. Figure 3 shows bacteria representative of multiple ac-
quired images. Expression of PagL resulted in the presence of
abundant OMV surrounding the cells. These OMV were remark-
ably homogeneous in size (approximately 50 to 120 nm). Fewer
OMV were seen in cells expressing the inactive variant of PagL or
the vector alone, in agreement with the amounts of KDO levels
detected in the supernatants. Together, these experiments suggest
that PagL activity leads to OMV formation in Salmonella cells.
To examine if the increase in OMV production upon PagL
overexpression is the result of envelope stress due to membrane
instability, we monitored three of the main systems involved in the
bacterial envelope stress response: the E, Cpx, and Rcs pathways
(50, 51). We used quantitative real-time PCR (RT-qPCR) to mea-
sure the effect of expressing PagL on the transcriptional levels of
key components in each pathway: rpoE, cpxR, and rcsC, which are
upregulated in response to the activation of their corresponding
pathways (50–52). rpoE codes for the main transcription factor
required for the upregulation of the E regulon during envelope
stress. CpxR is the response regulator in the Cpx pathway, while
RcsC is a key histidine kinase in the Rcs phosphorelay system.
FIG 2 In vitro expression of catalytically active PagL induces OMV production in S. Typhimurium. Shown is OMV fold production by S. Typhimurium strains
expressing PagL or PagLinactive relative to the control strain carrying the empty vector (VC). OMV preparations were obtained from OD600-normalized cultures,
and KDO content was determined using a colorimetric assay. The results were obtained from three independent experiments under the same conditions.
Presented are means standard errors of the means (SEM [n 3]). Statistical significance was determined using ANOVA followed by Tukey’s test.
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None of the previous genes was upregulated when PagL, or its
inactive variant, was overexpressed, indicating that PagL expres-
sion does not induce any of the envelope stress responses known
in S. Typhimurium (see Fig. S4 in the supplemental material).
PagL expression leads to accumulation of deacyated lipid A
in OMV. The previous results suggested a possible role of PagL in
OMV formation. According to our model, localized lipid A deacy-
lation at certain regions of the OM would cause its curvature.
Consequently, the released vesicles should be enriched in deacy-
lated lipid A. We compared the lipid A contents of OM and OMV
of S. Typhimurium upon overexpression of PagL. Lipid A was
purified and subjected to MS analysis. In the control strain carry-
ing the empty vector, both fractions displayed the same lipid A
species, and the spectra were similar to the ones obtained for cells
that did not carry the plasmid (see Fig. S5 in the supplemental
material). However, expression of PagL resulted in striking differ-
ences between the cellular lipid A and that purified from secreted
OMV. bis-Phosphorylated hexa-acylated lipid A (m/z 1,796) was
the predominant lipid A variant in the cellular fraction of PagL-
expressing bacteria (Fig. 4). This was also the main lipid A form
seen in bacteria not expressing PagL (see Fig. S1 in the supplemen-
tal material). Other less predominant forms were detected in the
cells, including the mono-phosphorylated hexa-acylated (m/z
1,716) and the bis-phosphorylated hepta-acylated lipid A (m/z
2,035). The formation of the hepta-acylated lipid A is mediated by
PagP, and an acyltransferase that attaches a palmitoyl group from
a phosphatidylglycerol donor to the 2 position in lipid A (53).
Importantly, the major peaks detected in the OMV fraction cor-
responded to deacylated forms of the lipid A species present in the
OM. The bis-phosphorylated penta-acylated lipid A (m/z 1,570)
was the most predominant form in OMV and corresponds to the
m/z 1,796 form minus the -hydroxymyristoyl substituent acyl
FIG 3 PagL expression induces OMV budding. S. Typhimurium cells grown in LB agar plates with 0.5 mM IPTG were resuspended in PBS and visualized by
transmission electron microscopy. vector, pEXT21 empty vector control; PagL, vector expressing active form of PagL; PagLinactive, vector expressing inactive
variant of PagL. Panels are representative of 40 images acquired per strain using a15,000 magnification.
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chain removed by PagL. Furthermore, the mono-phosphorylated
penta-acylated lipid A (m/z 1,490) and the bis-phosphorylated
hexa-acylated lipid A (m/z 1,808) were also prominent in the
OMV. These lipid A modifications were all PagL dependent since
we did not detect these forms in the S. Typhimurium strain car-
rying the empty vector.
PagL is required for OMV formation by intracellular S. Ty-
phimurium. Our biochemical analysis strongly supported the hy-
pothesis that PagL-mediated remodeling of LPS increases vesicu-
lation. To investigate the effect of PagL activity on vesiculation
under physiological conditions, we compared the wild type and its
isogenic pagL mutant strain for OMV production in J774A.1
mouse macrophages. Employing a monoclonal antibody highly
specific for the abequose residue present in S. Typhimurium O
antigen, we visualized the intracellular LPS by immunofluores-
cence. Following the staining of actin cytoskeleton in infected
macrophages, we employed confocal microscopy to detect intra-
cellular bacteria and OMV. In agreement with previous reports,
our microscopy analysis revealed the presence of material, com-
patible in size with OMV, that tested positive for LPS inside the
infected macrophages. These vesicles were detected in close vicin-
ity to and also apart from the intracellular bacteria (Fig. 5A). We
quantified the levels of intracellular OMV production by the two
strains employing the ImageJ software to count LPS-positive ves-
icles of diameter 250 nm and below (54). We chose the diameter of
250 nm as a cutoff for OMV size in agreement with previous re-
ports (2). We normalized the counted OMV by the number of
intracellular bacteria within the same macrophage. A total of 30
images per strain were used to measure the average amounts of
OMV produced per intracellular bacterium. Importantly, any
macrophages with LPS-positive particles between 250 nm and
0.5 m in size were considered to possibly contain lysed cells and
thus were excluded from our analysis. Using this method, we de-
tected about a 4-fold reduction in intracellular OMV secretion by
the pagL strain relative to the wild-type strain (Fig. 5B). Intra-
cellular OMV production was restored by the in trans expression
of pagL from its native promoter. On the contrary, the expression
of the inactive PagL variant in the pagL strain did not increase
intracellular vesiculation to wild-type levels (Fig. 5B). We postu-
lated that the apparent difference in vesiculation could be due to
an alteration in the subcellular localization of the strains associ-
ated with the disruption of the pagL strain. We monitored the
colocalization of intracellular bacteria with the vacuolar marker,
lysosomal associated membrane protein 1 (Lamp-1) (55). Using
this method, we found that the majority of intracellular bacteria
(approximately 80%) from both strains did not colocalize with
Lamp-1 (see Fig. S6A and B in the supplemental material). It has
been shown that Salmonella cells often escape the SCV of epithelial
cells and replicate in the cytoplasm (56–58). Transmission elec-
tron microscopy (TEM) at 4 h postinfection with wild-type and
pagL S. Typhimurium strains showed that the majority of intra-
cellular bacteria from both strains were detected in the cytoplasm
(Fig. 6), suggesting that the bacteria also escape the SCV in
J774A.1 macrophages.
DISCUSSION
Remodeling of the OM is one of the ways in which bacteria can
adapt to changing environments (32, 33, 40, 53). Blebbing of
OMV provides a rapid mean to dispense proteins that are no lon-
ger needed or that can be detrimental under the new condition.
Furthermore, OMV can be regarded as a long-distance toxin de-
livery mechanism (1, 2, 8). Various studies have provided com-
FIG 4 Deacylated lipid A is preferentially packed into S. Typhimurium OMV when PagL is expressed. Lipid A was purified from cells and OMV of an
S. Typhimurium strain expressing PagL from pWel2. MS analysis of the purified lipid A revealed the accumulation of deacylated lipid A species (marked by green
stars) in OMV compared to cells. The major deacylated lipid A species detected in OMV are bis-phosphorylated hexa-acylated lipid A (m/z 1,808), bis-
phosphorylated penta-acylated lipid A (m/z 1,570), and monophosphorylated penta-acylated lipid A (m/z 1,490). On contrary, the major lipid A forms that were
detected in cells had the-hydroxymyristoyl group at the 3 position of lipid A. The main cellular lipid A species detected were bis-phosphorylated hepta-acylated
lipid A (m/z 2,035), bis-phosphorylated hexa-acylated lipid A (m/z 1,796), and monophosphorylated hexa-acylated lipid A (m/z 1,716). Intens., intensity; a.u.,
arbitrary units. These results are representative of two independent experiments.
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pelling data that suggest the presence of selective machinery re-
sponsible for cargo selection in bacteria. In this regard, many
bacteria were found to preferentially pack proteins into their
OMV (10, 11, 14, 15, 59, 60). Other lines of evidence suggested
that the OMV cargo selection is not restricted to proteins but
extends to lipids, including phospholipids and lipid A (9, 13, 14).
These findings imply that membrane remodeling, in which
patches containing the OMV cargo are formed, precedes vesicu-
lation (13, 14, 16, 17). In this work, we investigated the effect of
membrane remodeling on OMV biogenesis by the lipid A deacy-
lase PagL in S. Typhimurium.
PagL is tightly regulated by the PhoPQ two-component sys-
tem, which is activated in S. Typhimurium inside the vacuole (19).
Growing the bacteria under natural PagL-inducing conditions
would activate other lipid A-modifying enzymes, making it very
difficult to draw conclusions (40, 41). For example, PagC, another
PhoPQ-activated protein, was proposed to be involved in OMV
formation (44). Moreover, some of these modifications were
FIG 5 PagL plays a role in intracellular vesiculation of S. Typhimurium. Shown are results from immunofluorescence-based detection of OMV (marked by
white arrows) production in J774A.1 mouse macrophages infected with different S. Typhimurium strains. Presented are the combined z-stacks for each infected
cell. After incubation, cells were fixed with 4% PFA, stained with monoclonal antiabequose to detect S. Typhimurium LPS (green), actin-specific phalloidin (red),
and DAPI (blue). Each image shown represents a set of 30 images. Scale bars represent 5 m (A). Intracellular OMV of different strains were counted using
ImageJ and normalized by the number of OMV-producing bacteria in each macrophage. Presented are the mean values obtained from 30 images (B). Statistical
significance (marked by asterisks) was determined using ANOVA followed by Tukey’s test (P 0.05).
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shown to inhibit PagL activity (39). We therefore recombinantly
expressed PagL in S. Typhimurium. TEM analysis of cells express-
ing the active version of the PagL revealed a dramatic increase
in the amounts of OMV on the periphery of bacteria. This was
only observed when cells were grown on solid media and not in
liquid (Fig. 3). Under these conditions, there were no differ-
ences between cells expressing PagL, PagLinactive, or the vector
control. This likely occurred due to the diffusion of the OMV to
the medium. This explanation is supported by the fact that the
levels of secreted OMV were elevated in the culture superna-
tants of PagL-expressing cells when cultured in liquid medium
(Fig. 2).
Intriguingly, the expression of PagL resulted in the accumula-
tion of deacylated lipid A species exclusively in the OMV (Fig. 4).
On the contrary, deacylated lipid A forms were not detectable in
cells expressing PagL. These results support our hypothesis that
the PagL-mediated changes in the structure of the lipid A contrib-
utes to generate membrane curvature and thus OMV formation
(Fig. 1). The effect of the degree of acylation on the shape of lipid
A is well studied. The number of acyl chains in lipid A affects the
angle by which the molecule is tilted to the membrane. Reducing
the number of lipid A acyl chains decreases the hydrophobic
cross-sectional area of the molecule, shifting its shape from a cone
to a cylinder or an inverted cone (35, 61). Therefore, we propose
that the accumulation of the deacylated lipid A in the OM desta-
bilizes the membrane and forces it to bend. This model is inspired
by the effects of lipid topology on membrane curvature that have
been described in eukaryotes (36). Lipids like lysophosphatidyl-
choline and phosphatidylinositol phosphates mediate the forma-
tion of positive membrane curvatures due to their inverted conical
shape. Conversely, lipids with small polar head groups relative to
their hydrophobic moiety mediate negative membrane curvature
(36). In this regard, the phospholipase A2 enzymatic activity
was found to generate membrane curvatures in the Golgi com-
plex through the accumulation of the released inverted-cone-
shaped lysophospholipids in the membrane (62–64). It is
tempting to speculate that accumulation of cone-shaped lipid
species with large hydrophobic moiety, such as cardiolipins, in
the OM inner leaflet is needed to alleviate the PagL-mediated
curvature. Indeed, it has been shown that PhoPQ activation
results in the accumulation of cardiolipins in the OM of S. Ty-
phimurium. Additionally, the PhoPQ-activated acyl trans-
ferase PagP generates triacylated acylphosphatidylglycerol spe-
cies in the OM (32, 33). These molecules, like cardiolipins, have
a small polar head and a large lipid moiety and therefore could
also participate in the process. Furthermore, it has recently
been proposed that in other bacteria, OMV can be generated
through the regulation of a phospholipid transporter at the
outer membrane (9). Thus, OMV formation is likely a multi-
factorial process that needs the orchestrated remodeling of
lipid A, phospholipids, and proteins.
The increase in vesiculation observed upon PagL induction
cannot be simply ascribed to a generalized membrane destabiliza-
tion phenomenon. We monitored the expression levels of key
players in the E, Cpx, and Rcs pathways, involved in bacterial
envelope stress response (50, 51). Our RT-qPCR analysis showed
that none of the previous pathways was activated when PagL or
FIG 6 Deletion of pagL did not alter the subcellular localization of S. Typhimurium. Shown is TEM examination of J774A.1 mouse macrophages at 4 h
postinfection with different S. Typhimurium strains. The majority of intracellular bacteria were detected in the cytoplasm (marked by black arrows). Examples
of intravacuolar bacteria are marked with red arrows. Each panel is representative of 15 different images obtained from 2 biological replicates.
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PagLinactive was expressed (see Fig. S4 in the supplemental mate-
rial).
Previous reports suggested that S. Typhimurium produces
OMV during its intracellular life. Garcia-del Portillo et al. de-
scribed the secretion of LPS into the intracellular milieu. It was
proposed that S. Typhimurium exploits the secreted LPS as sig-
naling molecules to interfere with the host cellular pathways (34).
Guidi et al. observed the intracellular secretion of CDT in S. Ty-
phimurium OMV using immunofluorescence, whereas LPS colo-
calized with CDT in vesicular structures (28). In our study, we
employed immunofluorescence and confocal microscopy to com-
pare the wild-type S. Typhimurium strain and a mutant lacking
PagL for the intracellular production of OMV. We employed a
lower than usual multiplicity of infection (MOI) to avoid the
masking of the phenotype by bacterial lysis or macrophage death.
Using LPS-specific monoclonal antibody, we tracked and quanti-
fied the OMV produced by intracellular bacteria. In agreement
with previous reports, we detected the production of OMV by the
S. Typhimurium wild-type strain. The strain lacking PagL dis-
played about 4-fold reduction in the release of intracellular OMV
compared to the wild-type strain. In trans expression of PagL from
its native promoter restored intracellular vesiculation in the mu-
tant, whereas expression of the inactive variant of PagL did not
complement the phenotype (Fig. 5A and B). To rule out the pos-
sibility that this phenotype was due to a defect in the subcellular
localization of the pagL mutant strain, we examined the intracel-
lular localization of wild-type and pagL strains. We employed
Lamp-1 as a marker for SCV. Surprisingly, our microscopy anal-
ysis showed that the majority of intracellular S. Typhimurium
wild-type and pagL bacteria were located in the cytoplasm of
J774.A macrophages. Deletion of pagL did not affect the intracel-
lular localization of S. Typhimurium (see Fig. S6A and B in the
supplemental material). Our TEM analysis of infected macro-
phages confirmed the results from our Lamp-1 colocalization as-
say (Fig. 6). Intracellular S. Typhimurium is known to reside in the
SCV, albeit it was shown that a subpopulation of bacteria escape
the SCV and replicate in the cytosol of epithelial cells (57, 58). Our
microscopy analysis shows that a significant cytoplasmic subpop-
ulation of S. Typhimurium exists in J774.A macrophages at 4 h
postinfection. However, our experiments do not show which sub-
population of bacteria is responsible for intracellular OMV secre-
tion. Although the OMV appear to be distributed throughout the
macrophage, OMV might be produced in the cytoplasm or by
bacteria within the SCV followed by their release into the cyto-
plasm upon lysis of the SCV. Our preferred hypothesis is that PagL
is induced in the SCV, where it remains latent due to the modifi-
cations of lipid A mediated by other PhoPQ-induced proteins.
Once bacteria are released from the SCV, LPS starts to be recycled.
PagL, which appears to be very stable, might able to deacylate the
new lipid A molecules with subsequent OMV biogenesis. Future
work will be needed to investigate the spatial and temporal loca-
tion of OMV production. Other studies will be also needed to
understand the relevance of OMV in pathogenesis, which is be-
yond the scope of this work.
Together, the above results suggest a role for lipid A deacyla-
tion in OMV biogenesis. A previous study suggested that the en-
velope remodeling events that occur during S. Typhimurium
growth and division might be responsible for OMV release (65).
As mentioned previously, OMV might be generated through the
regulation of a phospholipid transporter at the OM (9). These
models are not mutually exclusive, and it would be interesting to
analyze if these mechanisms are synergistically regulating OMV
production. Lipid A deacylation can be achieved by induction of
lipid A deacylases and also by repression of acyltransferases like
LpxM, which has been shown to be silenced upon infection in
bacteria such as Yersinia (66). PagL orthologs have already been
identified in multiple bacteria, suggesting that lipid A remodeling
could be involved in OMV biogenesis in diverse bacterial species
(42).
MATERIALS AND METHODS
Cell culture andmedia. J774A.1 mouse macrophages were maintained in
maintained in Dulbecco’s modified Eagle medium (DMEM [Life Tech-
nologies]) supplemented with 10% fetal bovine serum (FBS) at 37°C in a
humid atmosphere of 5% CO2. S. enterica subsp. enterica serovar Typhi-
murium 14028s was routinely cultured in Luria-Bertani (LB) medium.
When needed, antibiotics were supplemented at the following concentra-
tions: ampicillin, 100 g ml1; and spectinomycin, 100 g ml1.
OMV purification. Cultures from different S. Typhimurium strains
were normalized by their OD600 readings. Next, cells were pelleted down
at 5,000 rpm 4 C. In order to remove residual cells, the supernatant was
filtered using a 0.45-m-pore-size polyvinylidene difluoride (PVDF)
membrane followed by a 0.2-m PVDF membrane (Millex GV; Milli-
pore). The filtrate was subjected to ultracentrifugation at 100,000 g for
3 h to harvest OMV (Optima L-90K ultracentrifuge; Beckman Coulter).
The supernatant was discarded, the vesicle pellet was washed with sterile
PBS, and the ultracentrifugation step was repeated. The final vesicle pellet
was resuspended in PBS.
MALDI-MS analysis of lipid A. Lipid A from vesicles and cells was
prepared in duplicates using 10 mg of sample for each preparation accord-
ing to the procedure of Yi and Hackett (67). The purified lipid A was
resuspended in 6 l of methanol-dichloromethane (1:1). One microliter
of the mixture was loaded on the matrix-assisted laser desorption ioniza-
tion (MALDI) plate followed by addition of 0.5 l of 2,4,6-trihydroxy-
acetophenone monohydrate (THAP) as the matrix. MALDI-mass spec-
trometry (MS) was then performed on a Bruker Daltonics (Bremen,
Germany) UltrafleXtreme MALDI tandem time of flight (TOF/TOF)
mass spectrometer in the linear negative mode.
Cloning of PagL constructs. PagL was PCR amplified from the ge-
nome of S. Typhimurium 14028s using primers PagLEcoRIFw (ccccgaatt
cATGTATATGAAGAGAATATTTATATATC) and PagLBamHIRv (cccc
ggatccttagtggtggtggtggtggtgGAAATTATAACTAATTGAAGCACC). The
reverse primer included extra sequence coding for 6 histidine residues
at the C-terminal end of the protein. To include the native promoter of
PagL in the construct, primer PagLEcoRIFw was replaced by
PagLpromEcoRIFw (aattgaattcACAATGTGACATAACAGAAGTG).
The amplified product was restricted with EcoRI and BamHI, followed
by cloning in pEXT20 (68) to yield pWel1 (with PagL expressed from
the tac promoter) and pPagL (with PagL expressed from the native
promoter). Four random nucleotides were added at the 5’ end before
the restriction site in each primer. Restriction sites, the sequence cod-
ing for the histidine tag, and the additional four nucleotides at the 5’
end are all shown in lowercase letters in the aforementioned primer
sequences. To generate a catalytically inactive variant of PagL, site-
directed mutagenesis was used. pWel1 was used as the template for
primers PagLH163AS165AFw (ACAGAAGCTTATATCCGGGCCTTC
GCGAATGGATCACTTACGG) and PagLH163AS165ARv (CCGTAAGT
GATCCATTCGCGAAGGCCCGGATATAAGCTTCTGT) to change the
histidine and serine residues, at positions 163 and 165, respectively, to
alanine. The mutation was confirmed by Sanger sequencing, and the new
construct was named pMFH19. Similarly, pPagL was used as a template to
generate pPagLinactive, which codes for an inactive variant of PagL down-
stream of its native promoter. For expression in S. Typhimurium, pagL
and pagLinactive were subcloned from pWel1 and pMFH19 using the same
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cloning restriction sites into the low-copy-number vector pEXT21 (68),
to yield pWel2 and pWel6, respectively.
In vitro lipid A deacylation assay. The deacylase activity of different
PagL constructs was tested as shown before with some modifications (19).
In brief, total membranes were purified from different E. coli DH5ɑ
strains carrying pWel1, pMFH19, and pEXT20 grown to early stationary
phase after cell disruption of the cultures. Protein content of different
membrane preparations was determined using 2D-quant kit (GE Health).
S. Typhimurium 14028s LPS was extracted and used as a substrate for 5g
of the total membrane proteins obtained from different E. coli strains. The
reaction mixture was completed to 10 l with 50 mM HEPES (pH 8.0),
0.1% Triton X-100, 0.5 M NaCl, and 0.5 mM phenylmethylsulfonyl fluo-
ride. All reaction mixtures were incubated at 30°C overnight, followed by
lipid A extraction and MS analysis as stated above.
Immunoblotting. To test expression of PagL constructs in S. Typhi-
murium, whole-cell pellets were obtained from different strains after
normalization based on OD600 values. The harvested cell pellets were sol-
ubilized by boiling in 1 Laemmli buffer and then loaded on 12% SDS-
PAGE gel. Following separation, proteins were transferred to a nitrocel-
lulose membrane, and the PagL constructs were visualized using anti-His
polyclonal rabbit antibody (Rockland) followed by IRDye 680-labeled
anti-rabbit goat antibody (LI-COR Biosciences, Lincoln, NE). Images
were taken using the LI-COR Odyssey Imaging system (LI-COR Biosci-
ences, Lincoln, NE).
KDO-based quantification of OMV. To compare the amount of
OMV produced by different S. Typhimurium strains, OMV were purified
essentially as described above with some modifications. Cultures were
grown to the early exponential phase, followed by 4 h of induced expres-
sion of PagL constructs from pWel2 and pWel6 using 0.5 mM isopropyl
-D-1-thiogalactopyranoside (IPTG). After 4 h, OD600 readings were de-
termined. OMV were harvested from different strains after normalizing
them according to the OD600 readings of the cultures. Final OMV pellets
were resuspended in 100l of PBS, and OMV production was determined
by quantifying the KDO content in different preparations using the
method of Lee and Tsai (47). In brief, 50 l of OMV preparations was
boiled for 8 min with 0.5 M H2SO4 to release the KDO content, followed
by oxidation with 50 l of 0.1 M periodic acid. The latter reaction will
convert KDO to formylpyruvic acid. The addition of 0.2 M sodium arsen-
ite and freshly prepared thiobarbituric acid (0.6%), followed by boiling,
will yield a chromogen. The reaction product can be extracted using
n-butanol and measured spectrophotometrically at 552 nm and 509 nm.
Commercially available KDO (Sigma-Aldrich) was used as a standard. To
measure the KDO concentration in OMV preparations, the 552-nm read-
ings were subtracted by absorbance at 509 nm and the standard curve was
used to calculate the KDO content. The KDO concentrations of different
OMV preparations were normalized by that of the S. Typhimurium strain
carrying the empty vector to obtain OMV fold production relative to the
control strain. The results were obtained from three independent experi-
ments under the same conditions. A one-way analysis of variance
(ANOVA) followed by Tukey’s test to assess the significance of differences
between groups was performed. The differences were considered signifi-
cant when P was0.05.
RT-mediated qPCR. RT-mediated qPCR was carried out as described
before with some modifications (69). Total RNA was harvested from dif-
ferent strains at mid-log phase. As a positive control for envelop stress
response, mid-log-phase S. Typhimurium culture was subjected to a cold
shock at 4°C for 1 h. cDNA was synthesized using a SuperScript II cDNA
synthesis kit according to the manufacturer’s instructions (Invitrogen).
Quantitative real-time PCR (RT-qPCR) was used to determine differ-
ences in the expression of rpoE, cpxR, and rcsC using the housekeeping
gene rpoD for normalization. Relative quantification qRT-PCR was done
as described previously and analyzed using the threshold cycle (CT)
method (70). For each experiment, two biological replicates were in-
cluded and the average was presented. The primers used are listed in
Table S1 in the supplemental material.
Construction of pagL strain. An isogenic S. Typhimurium mutant
lacking pagL was created as described before (71). In brief, the FLP recom-
bination target (FRT)-flanked kanamycin resistance (Kmr) cassette was







TGTGTAGGCTGGAGCTGCTTCG). The latter primers included
around 100 bp (underlined) homologous to the sequences flanking pagL
in the genome. The amplified product was used to electroporate S. Typhi-
murium 14028s wild-type strain expressing Red recombinase from
pKD46. The recombinase-mediated allelic exchange resulted in the re-
placement of pagL by the kanamycin resistance cassette. Kmr transfor-
mants were selected and cured from pKD46 by growth at 37 C. The kana-
mycin resistance cassette was excised by the expression of FLP
recombinase from pFLP2. The pagL strain was cured from pFLP2 by
growth on 10% sucrose, which will induce the expression of the toxic
SacB. The clean deletion of pagL was confirmed by PCR amplification of
its flanking regions in the genome followed by sequencing of the amplified
product.
In vitro cell culture infectionmodel. Cell line J774A.1 mouse macro-
phages (ATCC TIB-67; ATCC, Rockville, MD) were seeded in a 24-well
tissue culture plate in Dulbecco’s modified Eagle medium (DMEM) sup-
plemented with 10% fetal bovine serum (FBS) at a density of 5 105 cells
per well overnight on 13-mm coverslips. The medium was changed to
serum-free DMEM, and infection was carried out as shown before with
slight modifications (72). Different S. Typhimurium strains were cultured
overnight in Luria-Bertani (LB) broth at 37°C. The next day, the strains
were subcultured until the early log phase. Then, different cultures were
washed and resuspended in DMEM to a final concentration of 0.4 OD
unit/ml. The macrophages were infected at a multiplicity of infection
(MOI) of 10:1. The culture plate was centrifuged for 1 min at 1,000 rpm
and incubated at 37°C for 30 min. Following incubation, fresh DMEM
with high concentration of gentamicin (100 g/ml) was added for 1 h to
kill extracellular bacteria. Next, the medium was changed to lower the
gentamicin concentration (50 g/ml), and incubation was continued for
3 h. After incubation, the cells were fixed with 4% paraformaldehyde PFA)
for 20 min, blocked in 2% goat serum and 1% bovine serum albumin
(BSA) (15 min). The intracellular salmonellae were stained with primary
monoclonal antibody directed against abequose (mouse monoclonal,
1:300 dilution, 0.1% Triton, 0.2% goat serum, 0.1% BSA) for 1 h, followed
by an incubation with the secondary antibody (anti-mouse Alexa 488,
1:500 dilution in 0.1% Triton, 0.2% goat serum, and 0.1% BSA). To stain
Lamp-1, rabbit polyclonal antibody was used (ab24170; Abcam), followed
by incubation with secondary antibody (Alexa Fluor 546-labeled anti-
rabbit). Actin was stained with Alexa Fluor 546- or Alexa Fluor 647-
labeled-phalloidin (1:40 dilution, 0.1% Triton, 0.2% goat serum, and
0.1% BSA) for 30 min and DAPI (4=,6-diamidino-2-phenylindole [1:
1,000 dilution], 0.1% Triton, 0.2% goat serum, 0.1% BSA) was used to
stain the nuclei. Slides were examined blindly using an Olympus IX-81
microscope with a Yokagawa spinning disk confocal head, 60 oil im-
mersion lens with a 1.42 numerical aperture, and a Hamamatsu electron
multiplying charge-coupled device (EMCCD) camera. Images were taken
with equal exposure time without saturation and analyzed with Volocity
imaging software. Illustrations were formatted, for noise reduction and
increased sharpness, using ImageJ (54). To determine size selection using
ImageJ, scale bars were used to set the scale for distance in pixels. The
minimal pixel size the Hamamatsu EMCCD camera can detect is 149 nm.
Therefore, the imaged vesicles ranged from 149 nm to 250 nm, while any
LPS-positive structures ranging from 250 nm up to 0.5 m were consid-
ered cell debris and the whole macrophage was discarded. The images
were exported into TIFF format with planes merged, transformed into
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Grayscale, and split into the 3 channels, with the threshold adjusted until
the bacteria were saturated, and vesicles were counted using the predeter-
mined scale. For pictures with multiple macrophages with vesicles, each
macrophage was measured separately. The intracellular localization of all
the counted subjects was confirmed by confocal microscopy examination
using z-stacks. A total of 30 images were used to assess intracellular vesicle
production by each strain. To validate our method, fluorescent beads
(Polysciences, Warrington, PA) of 1-m diameter were imaged under the
same conditions. The size of the beads was confirmed by using the scale
bar measurement set from the Salmonella vesicle images.
Transmission electron microscopy. For negative staining and analy-
sis by transmission electron microscopy, bacterial suspensions were al-
lowed to absorb onto freshly glow-discharged Formvar/carbon-coated
copper grids for 10 min. Grids were washed in dH2O and stained with 1%
aqueous uranyl acetate (Ted Pella, Inc., Redding, CA) for 1 min. Excess
liquid was gently wicked off, and grids were allowed to air dry. Samples
were viewed on a JEOL 1200EX transmission electron microscope (JEOL
United States, Peabody, MA) equipped with an AMT 8-megapixel digital
camera (Advanced Microscopy Techniques, Woburn, MA). To examine
Salmonella-infected host cells, J774A.1 mouse macrophages were infected
with S. Typhimurium as mentioned above. At 4 h postinfection, infected
cells were fixed overnight at 4°C in 4% glutaraldehyde–2% paraformalde-
hyde, 0.2 M sucrose, and 4 mM CaCl2 in 0.16 M sodium cacodylate buffer
(pH 7.4). Following washing with 0.05 M sodium cacodylate, lipids were
then fixed with 1% ice-cold osmium tetroxide (OsO4) in 0.05 M sodium
cacodylate buffer. Coverslips were blocked in en bloc stain with 1% uranyl
acetate in 0.1 M sodium acetate buffer (pH 5.2) for 15 min Sodium acetate
(0.1 M) was used to wash the coverslips, followed by Milli-Q filtered water
and increasing ethanol concentrations in propylene oxide. Cells were per-
meated with a mixture of EMbed 812 and Araldite 502 resins and embed-
ded on gelatin capsules. Thermal polymerization was performed at 60°C
for 48 h. Ultrathin sections with a thickness of 60 nm were generated using
a Leica UC7 ultramicrotome (Leica Microsystems, Inc.) and contrasted
with 2% uranyl acetate and Reynolds’ lead citrate. Sections were imaged
using a Hitachi H-7650 transmission electron microscope (Hitachi-High
Technologies) at 80 kV and a 16-megapixel TEM camera (XR111; Ad-
vanced Microscopy Techniques, Woburn, MA).
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